Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Cantor Fitzgerald
Boehringer Ingelheim
Fish and Richardson
Federal Trade Commission

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075199

« Back to Dashboard
NDA 075199 describes PENTOXIFYLLINE, which is a drug marketed by Watson Labs, Mylan, Valeant Pharms, Pliva, Heritage Pharms Inc, Actavis Elizabeth, Apotex, Impax Labs, and Teva, and is included in nine NDAs. It is available from twenty-one suppliers. Additional details are available on the PENTOXIFYLLINE profile page.

The generic ingredient in PENTOXIFYLLINE is pentoxifylline. There are fourteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.

Summary for NDA: 075199

Formulation / Manufacturing:see details

Pharmacology for NDA: 075199

Suppliers and Packaging for NDA: 075199

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TABLET, EXTENDED RELEASE;ORAL 075199 ANDA State of Florida DOH Central Pharmacy 53808-0757 53808-0757-1 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (53808-0757-1)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrength400MG
Approval Date:Sep 3, 1999TE:RLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Fish and Richardson
Queensland Health
Argus Health
US Department of Justice
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus